Biogaia AB
STO:BIOG B
Biogaia AB
STO:BIOG B
Price:
113.4 SEK
-0.61%
Market Closed
Updated:
May 6, 2024
Biogaia AB
Operating Income
|
Biogaia AB
Operating Income Peer Comparison
Comparables:
BONEX
VITR
PROB
SOBI
BIOA B
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biogaia AB
STO:BIOG B
|
Operating Income
kr443.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Operating Income
kr13.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Operating Income
-kr3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Probi AB
STO:PROB
|
Operating Income
kr11.3m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-5%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Operating Income
kr4.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
BioArctic AB
STO:BIOA B
|
Operating Income
kr264.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
See Also
What is Biogaia AB's Operating Income?
Operating Income
443.1m
SEK
443.1m
SEK
Based on the financial report for Dec 31, 2023, Biogaia AB's Operating Income amounts to 443.1m SEK.
What is Biogaia AB's Operating Income growth rate?
Operating Income CAGR 5Y
10%
10%
Over the last year, the Operating Income growth was 32%. The average annual Operating Income growth rates for Biogaia AB have been 25% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
